Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 8/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.52 |
| ▸ | CLK4 | Q9HAZ1 | 5/20 | 0.52 |
| ▸ | LMNA | P02545 | 5/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25570115 | 1.00 | CYP1A2 (0.52) | CYP1A2CYP3A4CLK4LMNACYP2D6 | |
| SCHEMBL25570143 | 0.97 | CLK4 (0.53) | CYP1A2CYP3A4CLK4LMNACYP2D6 | |
| SCHEMBL30041806 | 0.97 | CYP1A2 (0.54) | CYP1A2CYP3A4CLK4LMNACYP2D6 | |
| SCHEMBL30526034 | 0.97 | CLK4 (0.51) | CYP1A2CYP3A4CLK4LMNACYP2D6 | |
| SCHEMBL25570101 | 0.97 | CLK4 (0.51) | CYP1A2CYP3A4CLK4LMNACYP2D6 | |
| SCHEMBL24961153 | 0.97 | CYP1A2 (0.54) | CYP1A2CYP3A4CLK4LMNACYP2D6 | |
| SCHEMBL23105640 | 0.97 | CYP1A2 (0.54) | CYP1A2CYP3A4CLK4LMNACYP2D6 | |
| SCHEMBL22329585 | 0.97 | CLK4 (0.51) | CYP1A2CYP3A4CLK4LMNACYP2D6 | |
| SCHEMBL18015643 | 0.94 | CYP1A2 (0.57) | CYP1A2CYP3A4CLK4LMNACYP2D6 | |
| SCHEMBL29385966 | 0.93 | ABCG2 (0.50) | CYP1A2CYP3A4CLK4LMNACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167097-A1 | HETEROCYCLIC COMPOUND HAVING CYANO-SUBSTITUTION | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-06-01 | — | — | US | disclosed |
| US-20230167097-A1 | HETEROCYCLIC COMPOUND HAVING CYANO-SUBSTITUTION | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167097-A1 | HETEROCYCLIC COMPOUND HAVING CYANO-SUBSTITUTION | KCNH1, MCM4, MCM2 | CYP1A2 360/4885CYP3A4 284/4885CLK4 2465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.